TBIO - Telesis Bio Inc.
IEX Last Trade
3.31
1.950 58.912%
Share volume: 0
Last Updated: Fri 27 Sep 2024 08:27:03 PM CEST
Research and Development in the Physical, Engineering, and Life Sciences (except Nanotechnology and Biotechnology) :
0.82%
PREVIOUS CLOSE
CHG
CHG%
$1.36
1.95
143.38%
Fundamental analysis
21%
Profitability
0%
Dept financing
15%
Liquidity
75%
Performance
30%
Performance
5 Days
0 0%
1 Month
0 0%
3 Months
4.74%
6 Months
-34.32%
1 Year
523.08%
2 Year
78.68%
Key data
Stock price
$3.31
DAY RANGE
$2.35 - $3.30
52 WEEK RANGE
$0.39 - $15.46
52 WEEK CHANGE
$524.68
DIVIDEND
N/A
EX-DIVIDEND DATE
N/A
NEXT EARNINGS DATE
11/11/2024
Company detail
CEO: Todd R. Nelson
Region: US
Website: codexdna.com
Employees: 200
IPO year: -
Issue type: Common Stock
Market: XNAS
Industry: Research and Development in the Physical, Engineering, and Life Sciences (except Nanotechnology and Biotechnology)
Sector: Professional, Scientific, and Technical Services
Region: US
Website: codexdna.com
Employees: 200
IPO year: -
Issue type: Common Stock
Market: XNAS
Industry: Research and Development in the Physical, Engineering, and Life Sciences (except Nanotechnology and Biotechnology)
Sector: Professional, Scientific, and Technical Services
Codex DNA, Inc., a synthetic biology company, manufactures and sells synthetic biology instruments, reagents, and associated products and related services. Its solutions include BioXp system that empowers researchers to go from a digital DNA sequence to endpoint-ready synthetic DNA.
Recent news